Google News

Treasury sweeps biotech into proposed COINS Act restrictions, but spares Big Pharma’s China licensing deals - Fierce Biotech

Oct 23, 2026, 3:36 AM

Translate article text

Choose a language and wait for the translated text.

Treasury sweeps biotech into proposed COINS Act restrictions, but spares Big Pharma’s China licensing deals  Fierce Biotech